Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Awful quiet on the Eastbridge side the last 4 months, no new signings, no progress on those signed.
Dwarf where are you?
Bright side should see some positive results with 10k next month showing a large revenue increase over 2011.
benchman- they have been trying to get the RS for over 3 years now.
It is pretty much set.
What concerns be most about this position is timing. The company talks about spinning off Antigen but when?
If the reverse split goes though, and Antigen is spin off before
new funding (which makes sense for the insiders, less shares needed to distribute to GNBT share holders, less OS needed for the new company) they will not be enough equity in GNBT to sustain the price.
India might provide some temporary income, but Ora-lyn is being reformulated per CC. This means new trials and years added before marketing a product in the USA. ORMP will probably beat them to the market with a tablet form of insulin and kill the need for Ora-lyn.
Antigen may be a multi-billion dollar product. It just doesn't appear that current GBNT shareholders are going to see much of
that.
Example: Say you own 100,000 shares of GNBT. Say the share price is 8 cents. They do 100-1 reverse split to 8 dollars. They need a high enough price to get listed.
Now you own 1000 shares of GNBT. They now spin off Antigen, at a conservative rate of 20 to 1.
You will have 50 shares of Antigen and 1000 shares of GNBT.
IF Antigen goes to 100 dollars a share x 50 = 5000 dollars.
Who know what your 1000 shares of GNBT if it can't crack the US market.
The only thing that is going to matter here is whether or not CMBG
gets a product to market, If so the position will take care of it's self.
One good thing in our favor is the float is so low.
If you believe they will deliver don't watch for awhile, the float being so low there will probably be a lot of ups and downs. Until a marketable product is assured.
Their advantage is that it is oral tablet not an inhaled spray.
I was hot on this stock a few years ago. But now I think they missed the boat.
ORMP is very close to an oral insulin. That will kill this stock.
At current prices the R/$ will be closer to 100-150 to1.
I never said I believed any of those options will come though. I just reported what he told me.
Besides what can you do with those shares any way.
FYI concerning Tsingda shares.
Norm got back to me. He recommends holding on to the shares.
He thinks one of the following will occur.
Tsingda may still list in US.
Tsingda may list on Hong Kong exchange.
EBIG may try to sell the shares for us.
Tsingda may try to repurchase the shares from us.
A question that has not been asked or answered.
Ebig has sold it's shares of Tsingda, per 8k and conference call.
What happens to our share?
Apparently, you are new here. The major problem with this stock is and has been management publicly set goals for the company and has not come close to a single self imposed deadline.
Management has announced many many joint partnerships, and has not followed up on the outcomes.
Hopefully, the new management will only give out goals that the company will exceed.
In for the long haul.
Heard the replay of the conference call. I was surprised that no one asked what was going to happen to our shares of Tsingda since the company was staying private and EBIG has sold their shares.
The problem here is timing.
If the reverse split goes though, and Antigen is spin off before
new funding (which makes sense for the insiders, less shares needed to distribute to GNBT share holders, less OS needed for the new company) they will not be enough equity in GNBT to sustain the price.
Ora-lyn is being reformulated per CC. This means new trials and years added before marketing a product in the USA.
Antigen may be a multi-billion dollar product. It just doesn't appear that current GBNT shareholders are going to see much of
that.
Example: Say you own 100,000 shares of GNBT. Say the share price is 8 cents. They do 100-1 reverse split to 8 dollars.
Now you own 1000 shares of GNBT. They now spin off Antigen, at a conservative rate of 20 to 1.
You will have 50 shares of Antigen and 1000 shares of GNBT.
IF Antigen goes to 100 dollars a share x 50 = 5000 dollars.
Who know what your 1000 shares of GNBT will be worth with no US product to sell.
Jan 31 has come and gone, no merger announcement.
One can only hope, and not 20 cents.
What will make or break this new position, will be how fast CBMG gets it first product to market, and whether the street believes their tech is valued at 100 million.
From the conference call:
RS being voted on in March.
Ora-lyn to be reformulated before marketing in the USA. Current form to weak for the needs of Americans. Original formula will be marketed in India but not USA.
Management is delusional believe a RS split will strengthen stock support, but forgot that stock was on a higher exchange and could not hold minimum price, that why it is on the OTC now.
Antigen to be spun off as dividend, but after reverse split, so how many shares will current investors get for their investment now? Not many.
Have to figure, at 2 to 6 cents a share, RS split will have to be in the 150 to 1 range for them to be above minimum listing price.
After Antigen taken out of GNBT, and no Ora-lyn available in USA for several years (new strength new FDA testing) how will the company be able to maintain the stock price to remain listed on the higher exchange?
They being guilty, doesn't mean Spongetech wasn't legit.
Legit products with legit customers,
A few years back there was a news special done about the process at Walmart to get a product sold there.
The process is a long one.
Walmart sales specialist spend a lot of time checking out the companies, making sure the products will do what they say they will do, that the companies will be able to supply and keep up supply levels and they even tell the manufacture how much to charge for they product. This process may take years. If the manufacture fails any of these test the product will not be sold at Walmart.
Spongetech was sold at Walmart.
Legit product to a legit customer.
Trademark is a valuable access to any Corporation. No Corporation will license their Trademark to anyone they feel would harm or discredit their Trademark. A Corporation does not freely license it Trademarks are not just given to just anyone. Countless hours or research are done by the Corporation to make sure the company they are licensing their Trademark to, will use that Trademark in the spirit of the company image and that the agreement will produce a large momentary return to the Corporation.
Nickelodeon and Marvel (Disney) believed Spongetech would enhance their profits.
Legit contracts, using legit Trademarks, and selling legit products, with sales projections Nickelodeon and Marvel thought legit.
Why people invested here?
A few years back there was a news special done about the process at Walmart to get a product sold there.
The process is a long one.
Walmart sales specialist spend a lot of time checking out the companies, making sure the products will do what they say they will do, that the companies will be able to supply and keep up supply to the supply and they even tell the manufacture how much to charge for they product. This process may take years. If the manufacture fails any of these test the product will not be sold at Walmart.
Spongetech was sold at Walmart.
Trademark is a valuable access to any Corporation. No Corporation will license their Trademark to anyone they feel would harm or discredit their Trademark. A Corporation does not freely license it Trademarks are not just given to just anyone. Countless hours or research are done by the Corporation to make sure the company they are licensing their Trademark to, will use that Trademark in the spirit of the company image and that the agreement will produce a large momentary return to the Corporation.
Nickelodeon and Marvel (Disney) believed Spongetech would enhance their profits.
Why did people invest, because:
Nickelodeon thought they were legit and allow them to use 2 of their main characters.
Marvel though they were legit, giving them rights to their main character.
Independent TV stations doing test on their products gave them thumbs up.
NY Yankees, NY Mets, MSG, Chicago Bears, etc etc thought they were legit, signing 3 years contracts with them.
Amazon thought they were legit.
Costco thought they were legit.
Walmart thought they were legit.
Walgreen/CVS thought they were legit.
All those grocery stores that carried their product thought they were legit.
A lot of companies with a lot of expensive accountants and legal teams, whom you got to believe did their DD on Spongetech, when finished with that DD thought they were legit.
SPNGQ NSS should be so easy to follow in this electronic day and age.
Every certificate has a number, every sale has an electronic record of where that number goes.
It's not rocket science.
It should be a simple process to electronically back track whether or not a company sold more stock then it had or a hedge fund shorted stocks it did not have.
There is an electronic record of every sale and purchase.
We have the technology,
We choose not to use it.
Thanks
OT Ecomike
Do you believe CABN owns any real tech?
And do you think they will do anything with it?
Price and OS are so low that I was thinking it might be worth a little gamble, if there was real tech behind it.
Value your opinion, Thanks. If you prefer to stay on topic here please feel free to answer on CABN board.
Drug
Form 8-K for EASTBRIDGE INVESTMENT GROUP CORP
22-Jan-2013
Entry into a Material Definitive Agreement, Submission of Matter
Item 1.01. Entry into a Material Definitive Agreement
On January 15, 2012, EastBridge Investment Group Corporation ("EastBridge", the "Company", "we", "us" or "our"), CBMG Acquisition Limited, a British Virgin Islands company and the Company's wholly-owned subsidiary ("Merger Sub") and Cellular Biomedicine Group Ltd., a British Virgin Islands company ("CBMG", and collectively with EastBridge and Merger Sub, the "Parties") amended that certain Agreement and Plan of Merger (the "Merger Agreement" and the amendment, "Amendment No. 1 to the Agreement and Plan of Merger") previously entered into on November 13, 2012. Pursuant to Article II, Section 2.2 of the Merger Agreement the parties determined to extend the Drop Dead Date (as defined in the Merger Agreement) until January 31, 2013. No additional amendments were made to the Merger Agreement. A copy of Amendment No. 1 to the Agreement and Plan of Merger is attached as Exhibit 2.1 hereto.
Item 5.07. Submission of Matters to a Vote of Security Holders.
On January 17, 2013, the Company held its Special Meeting of Stockholders (the "Special Meeting"). At the meeting, stockholders (i) approved a change in our state of incorporation from Arizona to Delaware ("Proposal 1") and (ii) approved the Company's Amended and Restated 2011 Incentive Stock Option Plan ("Proposal 2").The affirmative vote of a majority of votes cast on the matter was required to approve Proposal 1 and Proposal 2.
Set forth below are the final voting results for each of the proposals:
Proposal 1 - Change of State of Incorporation
The change in our state of incorporation from Arizona to Delaware was approved. The voting results were as follows:
Votes For Votes Against Abstentions
80,831,538 882,063 23,817
Proposal 2 - Amended and Restated 2011 Incentive Stock Option Plan
The Amended and Restated 2011 Incentive Stock Option Plan was approved. The voting results were as follows:
Votes For Votes Against Abstentions
77,359,859 4,234,878 142,681
Item 8.01. Other Information.
On January 18, 2013, the Company issued a press release announcing the results of the Special Meeting. A copy of such press release is attached as Exhibit 99.1 hereto.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
2.1 Amendment No. 1 to the Agreement and Plan of Merger
99.1 Press release, dated January 18, 2013
Form 8-K for EASTBRIDGE INVESTMENT GROUP CORP
14-Jan-2013
Entry into a Material Definitive Agreement, Completion of Acquis
Item 1.01 Entry into a Material Definitive Agreement.
On December 17, 2012, EastBridge Investment Group Corporation (the "Company"), entered into a Securities Purchase Agreement (the "SPA") with Hui Zhang, the Chief Executive Officer of Tsingda eEDU Corporation, a Cayman Islands company ("Tsingda"), and MA Platform, Inc. (the "Purchaser"), pursuant to which the Company agreed to sell (the "Sale") to the Purchaser 1,424,129 ordinary shares (the "Shares") of Tsingda, at a price of $2.30 per share for an aggregate purchase price of $3,275,496.70 (the "Purchase Price").
The SPA contains customary representations, warranties and covenants of the parties. In addition, under the SPA, Norman P. Klein, the Company's Chief Financial Officer, and David Bolocan agreed to resign from their positions as Tsingda's directors. The SPA also provides for a deposit in an amount of 20% of the Purchase Price to be paid by Purchaser to the Company within 5 days after the execution of the SPA. A copy of the SPA is attached hereto as Exhibit 10.1.
Item 2.01. Completion of Acquisition or Disposition of Assets
On January 9, 2013, pursuant to the SPA, the Company consummated the Sale. In connection therewith, on December 19, 2012, Mr. Klein and Mr. Bolocan submitted their resignations to the board of directors of Tsingda.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
The following exhibits are filed with this Form 8-K.
Isn't today merger day?
Tyler
It the same and not.
If you own 100,000 shares of EBIG today and it went to 1 Dollar you would have a hundred thousand dollars.
After the reverse split (assuming 120 to 1 to get listed, currently at 5 cents to get to $6.00 ) the new stock price will have to be 120 dollars a share for you to be at a
hundred thousand dollars.
Ratio is the same, but the easy of a stock running from .01 to 1.00, much easier than a run of 1.20 to 120.00.
Especially, when 70% of your company value is based only on a made up number of what someone feels the tech is worth. A company with no real tangible assets and no marketable products at this time or any guarantees they will ever have any.
Remember CBMG is also sharing the management of EBIG, the management that has FAILED to meet any its own milestones in it's predicted time frames.
Let's hope CBMG launches it's first product by 2nd quarter of 13, or else you might see today's stock price after the reverse split.
Walt,
Where did you see this? I can't find any info anywhere.
Thanks
Any word on Dwarf?
Great, except after the reverse splits are done (most likely 100 - 1 to get listed) the new position will have to reach $100.00 a share to get to the value of a $1.00 we loyal EBIG shareholders were hoping for.
Anyone have a link to Saturday's PR?
As an investment NO, as entertainment YES.
If you happen to make the CC tomorrow question you should ask.
1)What is CBMG cash burn rate per month?
2)How much cash do they currently have in reserve to support on going clinical trials?
3)Is CBMG partnered with any major pharmaceutical companies currently?
4)What is the projected date CBMG has to have a sale-able product on the market?
5) What is EBIG basing CBMG current market value on?
6)What is the status of the 4 other companies EBIG stated would be listed in 2012.
7)If Tsindga valued itself as a major board stock why is it EBIG is having a hard time on settling on a price? (It should be no less than 4 dollars a share, based on Tsindga value of itself)
8) Would EBIG provide a certified audit of CBMG's value, to insure that CBMG is 70% more than that of EBIG, sothat the current EBIG shareholders are not being short changed in this merger?
Finally
9) Does current management of EBIG gain any new stock of stock options in the new merged company?
High school,
I was lucky having Math, Economics and History classes before 1pm.
What I learned in Math:
If I owned X % of hundred percent of a company, and that company valve rose 10% in value and also paid a stock dividend to it share holders. My personal value and dividend shares that I would own would be much greater than if I owned X % of 30% of the same company.
What I learned in economics:
If a company has no products to sell (assumption based on information of Cellular Biomedicine website) than that company is going to have no revenues.
I also learned about bringing drugs to market:
http://www.fdareview.org/approval_process.shtml
Your talking about a company needing millions of dollars and many years of testing, before having a product on the market and revenues.
What I learned in history
(Source EBIG press releases):
1)EastBridge Investment Group Announces Stock Dividend in General Farms
Friday November 16, 8:00 am
2)EastBridge Investment Group's Wholly Owned Subsidiary, Nanotek, Acquired by AREM Wine Company Thursday November 8, 8:00 am ET
3)EastBridge Investment Group Announces Stock Dividends From Three New Subsidiaries to Be Taken Public in United States
Thursday October 18, 7:55 am ET
4)EastBridge Investment Group Signs New Agreement With Rhino Two Horns to Take It Public in U.S. Monday November 26, 8:00 am ET
5)EastBridge Investment Group Announces Its Fifth Stock Dividend -- Record Holders of December 28, 2007 to Receive Dividend for EBIG's Energy Corporation Subsidiary Thursday December 20, 8:00 am
6)EastBridge Investment Group Signs Tenth Client - YEWO Group Corporation Tuesday March 18, 8:00 am ET
7)EastBridge Investment Group Begins Legal and Auditing Process for Amonics of Hong Kong to Go Public Tuesday April 8, 8:00 am ET
8)"EastBridge Investment Group in Final Stage to Acquire Controlling Interest in Two Chinese Companies Monday September 22, 8:00 am ET"
9)Oct 7, 2008 -- EastBridge Investment Group (EBIG) (OTC BB:EBIG.OB) today announced that it has signed a definitive listing agreement with HaoHai Media Company (HH Media), in Hangzhou, China, to take it public in the United States and list on a U.S. stock exchange
10)EastBridge Investment Group Files Form 8-K With SEC for the Acquisitions of Ji-Bo and Aoxing Corp. Thursday October 23, 8:00am
11)EastBridge Investment Group Taking Alpha Green Energy Company Public Coal Free Electricity Production Specialist Based in Phoenix, AZ Monday April 20, 2009, 8:00 am EDT
12)What happen to Jinkuizi Bio-Fertilizer Ltd,KaiDa Road Pavement and Construction Company,Fiber one, Long Whole Enterprises, Ltd.,
Tsingda Education Corporation, and Fizza LLC?
Out of all these company agreements since 2007 the only one to come to fruition is Wonder.
They have announce several joint ventures and acquisitions where are the revenues for these?
NO NEGATIVITY HERE JUST REALITY.
With that all said I hope Tuesday I am proven 100% wrong.
But I am expecting heavy snow job Tuesday around 10am EST
Rich
The merger IMHO stinks. Looking over the product line all you have is ideas, no products. Not one of their products have gotten though phase one yet. Which means they haven't proven that they work or are safe.
Even if they have a few ideas that will eventually become products it takes many years and lots of money for the required trials.
It seems to me with "acquired, transferred, commercialized and advanced thirty years of research and human treatment experience in progenitor cells and cancer cell technology" they would be a lot closer to launching a product then they are.
From what I see on their website this is nothing more than another penny stock company.
I hope I am wrong and they have some real value they are bringing to the merger.
Not one product pass phrase one. A long hold.
Major dilution coming, first lose 70% in merger, than reverse split to get listed, sad day.
Don't you find it strange, that they list they are working with 8 different companies, yet they report no earning for services rendered to these companies?
I know, owned it for 9 years.
Well said!